Ralfs Buks, PhD
Innovation Officer at EpitogenX- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Latvian Native or bilingual proficiency
-
Russian Limited working proficiency
-
French Limited working proficiency
Topline Score
Bio
Credentials
-
CMI Level 5 Certificate in Leadership and Managment
Chartered Management InstituteFeb, 2023- Nov, 2024
Experience
-
EpitogenX
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Innovation Officer
-
Feb 2023 - Present
Project management Collaboration set-up Stakeholder engagement Project management Collaboration set-up Stakeholder engagement
-
-
-
University of Aberdeen
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Honorary Research Fellow
-
Aug 2023 - Present
Multidisciplinary in vitro diagnostics (IVD) project write-up and participation
-
-
Post-Doctoral Research Fellow
-
Apr 2021 - Aug 2023
Antibody development - Generated 5 antibodies and developed 1 antibody as a practical research tool - Presented research and technologies at 5 international conferences, published 2 research articles, collaborated in 4 research/business projects
-
-
-
Vertebrate Antibodies
-
United Kingdom
-
Biotechnology Research
-
Knowledge Transfer Partnership Associate
-
Apr 2021 - Aug 2023
In vitro diagnostics (IVD) development - Assisted in pitch deck design and business proposal development resulting in a successful company buyout, which increased the company’s value 15-fold - Co-developed two Covid-19 diagnostic assays using two novel technologies, collaborating with the University of Aberdeen, Vertebrate Antibodies Ltd, and NHS Grampian In vitro diagnostics (IVD) development - Assisted in pitch deck design and business proposal development resulting in a successful company buyout, which increased the company’s value 15-fold - Co-developed two Covid-19 diagnostic assays using two novel technologies, collaborating with the University of Aberdeen, Vertebrate Antibodies Ltd, and NHS Grampian
-
-
-
INSERM
-
France
-
Research Services
-
700 & Above Employee
-
Marie Curie Early Stage Researcher
-
Sep 2016 - Mar 2021
Multidisciplinary and international PhD project in Haematology - Published 2 peer-reviewed research papers - Presented 2 oral and 6 poster presentations in international conferences - Awarded with 5 scholarships - Visiting researcher at Sanquin (Amsterdam, Netherlands), Nanion (Munich, Germany), Station Biologique de Roscoff (Roscoff, France) and the University of Bristol (Bristol, UK) Multidisciplinary and international PhD project in Haematology - Published 2 peer-reviewed research papers - Presented 2 oral and 6 poster presentations in international conferences - Awarded with 5 scholarships - Visiting researcher at Sanquin (Amsterdam, Netherlands), Nanion (Munich, Germany), Station Biologique de Roscoff (Roscoff, France) and the University of Bristol (Bristol, UK)
-
-
-
MedinCell
-
France
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Research and Development Intern
-
Aug 2014 - Aug 2015
- Developed and characterised 65 long acting drug injectable formulations - Designed study plans, reports and SOPs approved and used in the company - Developed and characterised 65 long acting drug injectable formulations - Designed study plans, reports and SOPs approved and used in the company
-
-
-
Weizmann Institute of Science
-
Israel
-
Research
-
700 & Above Employee
-
Summer Research Intern
-
Jun 2014 - Aug 2014
Immunology, Mice models and Microscopy Immunology, Mice models and Microscopy
-
-
-
Wellcome Trust Centre for Human Genetics, University of Oxford
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Summer Intern
-
Jul 2013 - Aug 2013
Genomics, R analysis Genomics, R analysis
-
-
Education
-
Chartered Management Institute
Diploma, Leadership and Management -
Université de Paris
Doctor of Philosophy (PhD), Physiology and Pathophysiology -
University of Aberdeen
Master in Science (M.Sci.), Genetics (Immunology) with Industrial Placement